---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-21-005077"
form_type: "8-K"
ticker: "BDSX"
cik: "0001439725"
company_name: "BIODESIX INC"
filed_at: "2021-12-08T23:59:59+00:00"
generated_at: "2026-06-28T02:47:21.102092+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Biodesix appoints Dr. Jon Faiz Kayyem to board of directors effective December 6, 2021

## Summary
- Dr. Kayyem brings 20+ years experience in molecular diagnostics, having founded GenMark Diagnostics and Clinical Micro Sensors.
- Initial equity grant of $375,000: 50,368 NQSOs (5-year vest) and 31,619 RSUs (1-year vest).
- Prorated annual grant of $87,397: 27,038 NQSOs vesting March 31, 2022, strike at close on December 7, 2021.
- Appointed to Compensation Committee effective December 7, 2021; term expires at 2024 Annual Meeting.

## SEC filing metadata
- accession: 0000950170-21-005077
- form_type: 8-K
- ticker: BDSX
- cik: 0001439725
- company_name: BIODESIX INC
- filed_at: 2021-12-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1439725/000095017021005077/0000950170-21-005077-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1439725/000095017021005077/bdsx-20211206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-21-005077
- JSON: https://secwatch.observer/filing/0000950170-21-005077.json
- Plain text: https://secwatch.observer/filing/0000950170-21-005077.txt

## Key facts
- Executive change
  Dr. Jon Faiz Kayyem was appointed as director at BIODESIX INC.
  - Action: appointed
  - Role: director
  source text: On December 6, 2021, Dr. Jon Faiz Kayyem was appointed to the Board of Directors of Biodesix, Inc. (the “Company”), effective December 6, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1439725/000095017021005077/0000950170-21-005077-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.